𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prognostic significance of the proportion of Ki-67-positive cells in adult t-cell leukemia

✍ Scribed by Yasuaki Yamada; Ken Murata; Sunao Atogami; Kunihiro Tsukasaki; Hisashi Sohda; Takao Yanagisako; Saburo Momita; Toru Jubashi; Tatsuhiko Amagasaki; Kazutaka Kuriyama; Yukinobu Oyakawa; Masuko Tagawa; Michito Ichimaru; Masao Tomonaga; Shimeru Kamihira; Ken-Ichiro Kinoshita

Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
481 KB
Volume
67
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Differences in prognostic factors betwee
Differences in prognostic factors between leukemia and lymphoma type of adult t-cell leukemia
✍ Yoshinori Shimamoto; Kazutoshi Ono; Masayuki Sano; Miwako Matsuzaki; Kenji Suga; πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 435 KB πŸ‘ 1 views

analysis, the patients were divided into two groups: those with the leukemia type ATL and those with the lymphoma type. The prognostic factors have been evaluated separately for each of the types as well.

Significance of soluble interleukin-2 re
Significance of soluble interleukin-2 receptor levels for evaluation of the progression of adult T-cell leukemia
✍ Shimeru Kamihira; Sunao Atogami; Hisashi Sohda; Saburo Momita; Yasuaki Yamada; M πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 485 KB πŸ‘ 2 views

Background. The authors conducted a survey of a large cohort of patients with adult T-cell leukemia (ATL) and a group of human T-cell leukemia virus type 1 (HTLV-1) carriers to elucidate whether measurements of soluble interleukin-2 receptor (sIL-2R) levels are indicative of ATL tumor burden and cor

Recombinant interferon beta and gamma in
Recombinant interferon beta and gamma in the treatment of adult T-cell leukemia
✍ Kazuo Tamura; Shigeyoshi Makino; Yasuhiko Araki; Takuroh Imamura; Masashi Seita πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 372 KB πŸ‘ 2 views

Adult T-cell leukemia (ATL) is one of the most difficult diseases to treat because of severe underlying immune deficiency and metabolic disturbance. Interferon has potent antiviral, antiproliferative, and immunomodulating properties, and therefore, this may be a good agent to treat such immune defic